Chutzpah Holdings Ltd bought $4.5M of Pluri (PLUR)
Executed Apr 28 2025, disclosed Jul 1 2025, 64 days later, against a two-business-day limit.
Over the 21 trading sessions from the disclosed entry session (Jul 1 2025), the stock returned +6.5% (delay-adjusted); from the execution session (Apr 28 2025), -14.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Chutzpah Holdings Ltd (Director) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales, 1 filed past the two-business-day deadline), most often in Pluri Inc. (PLUR). Across 1 priced purchase filing, the average 21-session return was -14.2% from execution and +6.5% from disclosure (delay-adjusted; derived). The largest single filing was $4.5M of PLUR (976,139 sh across 2 lots, as filed), executed Apr 28 2025.
Healthcare · Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and r…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→